Reply to comment on: Clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial.

Bhalla, Ashok K; Bhalla, Ashley S; Coates, Laura C; Packham, Jon C; Creamer, Paul; Hailwood, Sara; Chakravarty, Kuntal; Mulherin, Diarmuid; Taylor, Gordon; Mattey, Derek L

Bhalla, Ashok K; Bhalla, Ashley S; Coates, Laura C; Packham, Jon C; Creamer, Paul; Hailwood, Sara; Chakravarty, Kuntal; Mulherin, Diarmuid; Taylor, Gordon; Mattey, Derek L.

Afiliação

Bhalla AK; Royal National Hospital for Rheumatic Diseases, Bath, UK. ashok.bhalla@nhs.net.
Bhalla AS; Royal National Hospital for Rheumatic Diseases, Bath, UK.
Coates LC; Tameside Hospital, Ashton-under-Lyme, Lancashire, UK.
Packham JC; Haywood Rheumatology Centre, Stoke on Trent, UK.
Creamer P; Southmead Hospital, Bristol, UK.
Hailwood S; Rheumatic Disease Unit, Whyteman's Brae Hospital, Kirkcaldy, Fife, UK.
Chakravarty K; Royal Free Hospital NHS Foundation Trust, London, UK.
Mulherin D; Royal Wolverhampton NHS Trust, Cannock Chase Hospital, Brunswick Road, Staffordshire, UK.
Taylor G; Royal National Hospital for Rheumatic Diseases, Bath, UK.
Mattey DL; Institute of Science and Technology in Medicine, Keele University, Keele, Staffordshire, UK.

Clin Exp Rheumatol ; 35(3): 549, 2017.

Article em En | MEDLINE | ID: mdl-28421992

Assuntos

Alendronato; Espondilite Anquilosante; Antirreumáticos; Método Duplo-Cego; Humanos; Resultado do Tratamento

Buscar no Google

Imprimir

XML

PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espondilite Anquilosante / Alendronato Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Buscar no Google

Imprimir

XML

PubMed Links